EODData

NASDAQ, BCAB: Bioatla Inc

19 Dec 25 15:59
LAST:

0.7511

CHANGE:
 0.04
OPEN:
0.8075
HIGH:
0.8100
ASK:
0.0000
VOLUME:
878.4K
CHG(%):
4.89
PREV:
0.7921
LOW:
0.7500
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Dec 250.78100.80990.75000.7534959.1K
18 Dec 250.78000.83230.74040.7921824.0K
17 Dec 250.76000.83000.74130.78251.36M
16 Dec 250.75000.80000.73710.76011.03M
15 Dec 250.82500.87930.74040.77231.26M
12 Dec 250.78830.85680.78010.8244979.3K
11 Dec 250.79000.79990.75010.7832608.5K
10 Dec 250.77750.80400.75010.77371.07M
09 Dec 250.81600.84000.79000.8053657.6K
08 Dec 250.85000.85130.78750.8100834.9K

PROFILE

Name:Bioatla Inc
About:BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and squamous cell carcinoma of head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:11085 Torreyana Road, San Diego, CA, United States, 92121
Website:https://www.bioatla.com
CUSIP:09077B104
CIK:0001826892
ISIN:US09077B1044
FIGI:BBG00Y6GBT61

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.55 
Forward P/E:-0.44 
PEG Ratio:0.02 
Price to Sales:3.48 
Price to Book:-2.32 
Operating Margin:-5.75 
Return on Assets:-0.83 
Return on Equity:-8.14 
EPS Ratio:-1.10 
Revenue:11.0M 
Shares:58.72M 
Market Cap:44.11M 

TECHNICAL INDICATORS

MA5:0.772.8%
MA10:0.794.6%
MA20:0.818.1%
MA50:0.795.2%
MA100:0.6712.5%
MA200:0.5341.9%
RSI14:44.37
WPR14:-100.00 
MTM14:-0.03
ROC14:-0.03 
ATR:0.07 
Week High:0.8817.1%
Week Low:0.741.9%
Month High:1.4390.4%
Month Low:0.7041.9%
Year High:1.4390.4%
Year Low:0.24213.0%